Afuco™ Anti-Human RPSA ADCC Therapeutic Antibody, ADCC Enhanced
Anti-RPSA ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-LRP/LR specific antibody IgG1-iS18 by binding to laminin receptor (LRP/LR) may act as a possible alternative therapeutic tool for metastatic breast and oesophageal cancer treatment.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-653CL |
| Pricing | Inquiry |
| Type | ADCC enhanced antibody |
| Storage | Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |
| Target | RPSA |
| Species Reactivity | Human |